Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
22nd Century Group, Inc. XXII
$0.65
+$0.01 (0.79%)
На 18:00, 12 мая 2023
+746.15%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
140069273.00000000
-
week52high
2.70
-
week52low
0.61
-
Revenue
62111000
-
P/E TTM
-3
-
Beta
1.79930700
-
EPS
-0.30000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 10:00
Описание компании
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Alliance Global Partners | Buy | 21 июл 2022 г. | |
| Craig-Hallum | Buy | 15 июн 2022 г. | |
| Roth Capital | Buy | 08 мар 2022 г. | |
| Cowen & Co. | Outperform | 23 июл 2021 г. | |
| Chardan Capital | Buy | Buy | 26 янв 2018 г. |
| Alliance Global Partners | Buy | Buy | 09 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| SALHANY LUCILLE S | A | 27612 | 27612 | 21 сент 2022 г. |
| ZERCHER MICHAEL | D | 904938 | 370789 | 31 авг 2022 г. |
| FRANZINO JOHN | D | 405574 | 20324 | 14 июн 2022 г. |
| SULLIVAN NORA B | D | 0 | 100000 | 16 мая 2022 г. |
| SULLIVAN NORA B | A | 748707 | 100000 | 16 мая 2022 г. |
| ZERCHER MICHAEL | D | 1275727 | 210742 | 21 мар 2022 г. |
| Johnson Anthony L. | A | 91808 | 51808 | 21 мар 2022 г. |
| Koganov Michael | A | 179372 | 51808 | 21 мар 2022 г. |
| FLEET CLIFFORD B | A | 256195 | 51808 | 21 мар 2022 г. |
| O'BRIEN ROGER D | A | 308595 | 51808 | 21 мар 2022 г. |
Новостная лента
22nd Century Group (XXII) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
09 мая 2023 г. в 08:24
22nd Century Group (XXII) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.05 per share a year ago.
22nd Century Group (Nasdaq: XXII) to Announce First Quarter 2023 Results on May 9, 2023
GlobeNewsWire
03 мая 2023 г. в 09:15
BUFFALO, N.Y., May 03, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, will host a live webcast on Tuesday, May 9, 2023, at 10:00 AM ET to discuss its 2023 first quarter results, which are to be reported in a press release at 6:00 AM ET the same day.
22nd Century Group, Inc. (XXII) Q4 2022 Earnings Call Transcript
Seeking Alpha
09 мар 2023 г. в 14:46
22nd Century Group, Inc. (XXII) Q4 2022 Earnings Conference Call March 9, 2023 10:00 AM ET Corporate Participants Matt Kreps - Investor Relations Jim Mish - Chief Executive Officer John Miller - President, Tobacco Business Hugh Kinsman - Chief Financial Officer Conference Call Participants Aaron Grey - Alliance Global Partners Vivien Azer - TD Cowen Alex Fuhrman - Craig-Hallum Capital Group Brian Wright - ROTH MKM Jim McIlree - Dawson James Operator Good day, ladies and gentlemen, and welcome to the 22nd Century Group's Fourth Quarter and Year-End Results Conference Call. At this time all lines are in a listen-only mode.
22nd Century Group (XXII) Reports Q4 Loss, Lags Revenue Estimates
Zacks Investment Research
09 мар 2023 г. в 08:24
22nd Century (XXII) delivered earnings and revenue surprises of -100% and 0.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
22nd Century Group (Nasdaq: XXII) to Participate in March 2023 Roth Investor Conference
GlobeNewsWire
02 мар 2023 г. в 16:15
BUFFALO, N.Y., March 02, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced that the Company will be participating in one-on-one meetings during the 35th Annual Roth Conference, to be held March 12-14, 2023 in Orange County, California.